嵌合抗原受体
细胞毒性T细胞
抗原
球体
肿瘤微环境
细胞
T细胞
癌症研究
细胞毒性
流式细胞术
癌细胞
化学
癌症免疫疗法
免疫疗法
细胞生物学
免疫学
生物
癌症
细胞培养
免疫系统
体外
生物化学
遗传学
作者
Youngbin Cho,Matthew Laird,Teddi Bishop,Ruxuan Li,Elisa Ruffo,Jason Lohmueller,Ioannis K. Zervantonakis
出处
期刊:
[Cold Spring Harbor Laboratory]
日期:2024-03-15
被引量:1
标识
DOI:10.1101/2024.03.14.585033
摘要
Abstract The success of chimeric antigen receptor (CAR) T cells in blood cancers has intensified efforts to develop CAR T therapies for solid cancers. In the solid tumor microenvironment, CAR T cell trafficking and suppression of cytotoxic killing represent limiting factors for therapeutic efficacy. Here, we present a microwell platform to study CAR T cell interactions with 3D tumor spheroids and determine predictors of anti-tumor CAR T cell function. To precisely control antigen sensing by CAR T cells, we utilized a switchable adaptor CAR system, that instead of directly binding to an antigen of interest, covalently attaches to co-administered antibody adaptors that mediate tumor antigen recognition. Following addition of an anti-HER2 adaptor antibody, primary human CAR T cells exhibited higher infiltration and clustering compared to the no adaptor control. By tracking CAR T cell killing at the individual spheroid level, we showed the suppressive effects of spheroid size and identified the initial CAR T cell : spheroid area ratio as a predictor of cytotoxicity. Spatiotemporal analysis revealed lower CAR T cell numbers and cytotoxicity in the spheroid core compared to the periphery. Finally, increasing CAR T cell seeding density, resulted in higher CAR T cell infiltration and cancer cell elimination in the spheroid core. Our findings provide new quantitative insights into CAR T cell-mediated killing of HER2+ breast tumor cells. Given the miniaturized nature and live imaging capabilities, our microfabricated system holds promise for discovering cell-cell interaction mechanisms that orchestrate antitumor CAR T cell functions and screening cellular immunotherapies in 3D tumor models.
科研通智能强力驱动
Strongly Powered by AbleSci AI